Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

FLRG and follistatin have different roles in wound healing.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

Temporary activation of β-catenin can create new hair follicles, but ongoing activation is needed to keep hair follicle tumors.

Stress increases nerve growth factor, causing hair loss in mice.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.

Some thymic peptides can increase human hair growth, while others may inhibit it.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

FOL-026 peptide may help hair growth and cardiovascular health by improving blood flow and cell functions.

Disrupting Notch signaling in blood vessels increases scarring during wound healing in mice.

Ca_v1.2 affects hair growth and could be a target for hair loss treatments.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

A soluble factor in developing mouse whisker pads boosts nerve growth factor mRNA production.

Lower growth factors linked to balding in androgenetic alopecia.

Plant-made bFGF helps cells grow and boosts collagen.

Tofacitinib may help treat severe childhood alopecia areata, but risks require careful consideration.

A balance between BMP and Wnt signals is crucial for hair follicle stem cell function and hair growth.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

Cyclosporin A, a drug, reduces TGF-β2 expression in skin cells, potentially causing excessive hair growth through a process involving the calcineurin/NFAT pathway.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Early diagnosis and treatment are crucial to prevent permanent hair loss from TNFα inhibitors in scalp psoriasis.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

TGF-β1 and 2 in hair follicles may be linked to hair loss in AGA.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Androgens help motor neurons grow by increasing neuritin.